FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/DVA
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Davita Inc (DVA) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

DaVita (DVA) trades at $181.69, down 1.06% on the day, with strong technical support at $182 and resistance at $187. The company demonstrates consistent earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88. Revenue growth has been steady, reaching $13.64B in 2025, while maintaining a 6.05% net income margin. Recent developments include expanded value-based care partnerships with Humana, positioning the company for continued growth in kidney care services.
DVA presents a compelling investment case with a reasonable P/E of 15.6 and analyst consensus price target of $235.67, representing 30% upside potential. However, investors face risks from rising debt levels (debt-to-asset ratio increased to 65.55% in 2025) and regulatory pressures in healthcare. The stock's 635.3% ROE, while impressive, reflects minimal equity base rather than exceptional profitability.
Read full analysis

Key Stats

  • Market Cap
    $11.74B
  • Volume
    570,362
  • Sector
    Health
  • 52W High
    $240.96
  • 52W Low
    $103.87
  • Typical Hold Time
    116 Days
  • Enterprise Value
    $24.46B
  • Div Yield
    -
  • Trading Activity
    93% Sell | 7% Buy
$181.95
52W Low: $103.87
14 Jan 2026
52W High: $240.96
29 Jul 2026

Track Davita Inc (DVA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Davita Inc has traded between a low of $103.87 and a high of $240.96, highlighting its annual price range. Buy and sell Davita Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Most Recent News

Content is generated by Aura AI

LUXEED launches global media test drive showcasing luxury MPV LLounge and sports model Stormax.

LUXEED held a global media test drive event in Wuhu with 15 automotive media and influencers from UAE, Thailand, and Indonesia. Participants evaluated the luxury MPV LLounge and sports model Stormax over a 185-km route combining highways and mountain...

Market News
1 hour ago
Not Specified
Bullish
news icon
LUXEED launches global media test drive showcasing luxury MPV LLounge and sports model Stormax.

India's plastics market to reach $68.41B by 2032, driven by packaging and electric vehicle demand.

India's plastics industry is projected to grow from USD 49.98 billion in 2027 to USD 68.41 billion by 2032, at a CAGR of 6.48%. Growth is fueled by rising demand in packaging, pharmaceuticals, electric two-wheelers, and construction, alongside polyme...

Market News
2 hours ago
Mordor Intelligence
Bullish
news icon
India's plastics market to reach $68.41B by 2032, driven by packaging and electric vehicle demand.

Natera, Impinj, and Hamilton Lane beat earnings expectations; Cardinal Infrastructure lags despite strong revenue.

Natera and Impinj reported stronger-than-expected quarterly results, with Impinj achieving record revenue and profitability. Hamilton Lane also exceeded revenue and earnings forecasts, positively impacting its shares. However, Cardinal Infrastructure...

4 hours ago
Seeking Alpha
Neutral
Natera, Impinj, and Hamilton Lane beat earnings expectations; Cardinal Infrastructure lags despite strong revenue.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.74B
  • Volume
    570,362
  • Sector
    Health
  • 52W High
    $240.96
  • 52W Low
    $103.87
  • Typical Hold Time
    116 Days
  • Enterprise Value
    $24.46B
  • Div Yield
    -
  • Trading Activity
    93% Sell | 7% Buy
$181.95
52W Low: $103.87
14 Jan 2026
52W High: $240.96
29 Jul 2026

Track Davita Inc (DVA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Davita Inc has traded between a low of $103.87 and a high of $240.96, highlighting its annual price range. Buy and sell Davita Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!